NEUCA S.A.

Warsaw Stock Exchange NEU.WA

NEUCA S.A. Goodwill for the year ending December 31, 2023: USD 247.30 M

NEUCA S.A. Goodwill is USD 247.30 M for the year ending December 31, 2023, a 49.15% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

NEUCA S.A. Goodwill for the year ending December 31, 2022 was USD 165.81 M, a 4.06% change year over year.
NEUCA S.A. Goodwill for the year ending December 31, 2021 was USD 159.35 M, a 54.13% change year over year.
NEUCA S.A. Goodwill for the year ending December 31, 2020 was USD 103.39 M, a 27.06% change year over year.
NEUCA S.A. Goodwill for the year ending December 31, 2019 was USD 81.37 M, a 1.14% change year over year.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

Warsaw Stock Exchange: NEU.WA

NEUCA S.A.

CEO	Mr. Piotr Sucharski
IPO Date	Nov. 22, 2004
Location	Poland
Headquarters	ul. Forteczna 35-37
Employees	4,633
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Biotechnology Hospitals & Clinics Insurance Perfumes & Fragrances Personal Care Pharmaceuticals

Description

NEUCA S.A. engages in the distribution of pharmaceuticals to pharmacies and hospitals in Poland. It operates through Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials and Telemedicine segments. The company also provides advertising and marketing services; pharmaceutical products under its own brand; clinical trial, telemedicine, agency, financial, road cargo transport, accounting and bookkeeping, software, hospital, and information technology and computer related services; and health, property, and other personal insurance products. In addition, it operates outpatient care clinics and medical stores. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.

Key trends

Past 5 years